Results 1 - 10 of 10
- Antiviral drug discovery: broad-spectrum drugs from nature. J. P. Martinez, F. Sasse, M. Brönstrup, J. Diez, A. Meyerhans
, Nat. Prod. Rep.
, 2015
, 32
, 29
- Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection. Steven J. Moss, Michael Bobardt, Pieter Leyssen, Nigel Coates, Udayan Chatterji, Xie Dejian, Teresa Foster, Jinlun Liu, Mohammad Nur-e-Alam, Dipen Suthar, Chen Yongsheng, Tony Warneck, Ming-Qiang Zhang, Johan Neyts, Philippe Gallay, Barrie Wilkinson, Matthew A. Gregory
, Med. Chem. Commun.
, 2012
, 3
, 944
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Synthesis of MeBmt and related derivatives via syn-selective ATH-DKR. Adam Rolt, Paul M. O'Neill, T. Jake Liang, Andrew V. Stachulski
, RSC Adv.
, 2019
, 9
, 40336
- In-cell NMR: from metabolites to macromolecules. G. Lippens, E. Cahoreau, P. Millard, C. Charlier, J. Lopez, X. Hanoulle, J. C. Portais
, Analyst
, 2018
, 143
, 620
- Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. Gamal El-Din A. Abuo-Rahma, Mamdouh F. A. Mohamed, Tarek S. Ibrahim, Mai E. Shoman, Ebtihal Samir, Rehab M. Abd El-Baky
, RSC Adv.
, 2020
, 10
, 26895
- Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase: synthesis, structure–activity relationship studies and antiviral activity. Jiahong Li, Sona Kovackova, Szuyuan Pu, Jef Rozenski, Steven De Jonghe, Shirit Einav, Piet Herdewijn
, Med. Chem. Commun.
, 2015
, 6
, 1666
- Natural products to drugs: natural product-derived compounds in clinical trials. Mark S. Butler
, Nat. Prod. Rep.
, 2008
, 25
, 475
- When iron met phosphines: a happy marriage for reduction catalysis. Luis C. Misal Castro, Haoquan Li, Jean-Baptiste Sortais, Christophe Darcel
, Green Chem.
, 2015
, 17
, 2283
- Chemical genetics. Cornelius J. O' Connor, Luca Laraia, David R. Spring
, Chem. Soc. Rev.
, 2011
, 40
, 4332